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Background: Although the maze procedure is an established surgical treatment for eliminating atrial fibrillation
(AF), its efficacy in patients with mitral valve disease has remained unsatisfactory. A useful predictive marker for the
outcome of the maze procedure is needed. The aim of this study was to investigate whether the preoperative ratio
of atrial natriuretic peptide (ANP) to brain natriuretic peptide (BNP) reflects atrial fibrosis and can be used to predict
the maze procedure outcome in patients with mitral valve disease.
Methods: A total of 23 consecutive patients who underwent the radial approach to the maze procedure combined
with mitral valve surgery were included in this study and were divided into a sinus rhythm (SR) group (n=16) and
an AF group (n=7) based on postoperative cardiac rhythm. Plasma samples were obtained at rest before the
operation and were analysed for ANP and BNP levels. Atrial tissue samples taken during surgery were used to
quantify interstitial fibrosis.
Results: The preoperative ANP-to-BNP ratio in the SR group was significantly higher than that in the AF group
(0.74 +/− 0.29 vs. 0.42 +/− 0.28, respectively; p=0.025). Receiver operating characteristic (ROC) curve analysis was
used to identify factors that predict outcomes after the maze procedure. The area under the ROC curve for the
ANP-to-BNP ratio (0.81) was greater than for any other preoperative factors. Moreover, the preoperative ANP-to-BNP
ratio demonstrated a negative correlation with left atrial fibrosis (r=−0.69; p=0.003).
Conclusions: The preoperative ANP-to-BNP ratio can predict maze procedure outcome in patients with mitral valve
disease, and it represents a potential biomarker for left atrial fibrosis.
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Atrial fibrillation (AF) is the most common cardiac ar-
rhythmia, especially for patients with mitral valve dis-
ease. The presence of postoperative AF is a significant
risk factor for postoperative mortality, stroke, and other
thromboembolism and anticoagulant-related haemor-
rhage [1]. Therefore, the restoration of sinus rhythm
(SR) is critical for patients with AF and mitral valve
disease who underwent mitral valve surgery. The maze* Correspondence: mikamo@yamaguchi-u.ac.jp
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reproduction in any medium, provided the orprocedure is an established surgical treatment for elimi-
nating AF. The procedure reduces cardiovascular mor-
tality and stroke and improves cardiac function [1,2].
Furthermore, its success rate for treating lone AF is higher
than 90% [3]. However, only success rates between 60%
and 90% have been reported with the maze procedure in
patients with mitral valve disease [4,5]. Because the maze
procedure has potential disadvantages, including pro-
longed operation and crossclamp times and the occasional
need for implantation of a permanent pacemaker, per-
forming this invasive procedure in patients who are less
likely to receive a benefit should be avoided.
Atrial fibrosis plays an important role in developing and
maintaining AF. Yoshihara et al. reported that the collagend. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[6]. However, previous risk factors for failure of the maze
procedure, such as left atrial diameter (LAD), duration of
AF and cardiothoracic ratio (CTR) [7,8], do not correlate
well with atrial fibrosis [6,9]. Moreover, these risk factors
do not fully predict the outcomes of the maze procedure.
It has been reported that atrial natriuretic peptide (ANP)
and brain natriuretic peptide (BNP) are related to atrial
remodelling [6,10]. Furthermore, Mabuchi et al. reported
that the ANP-to-BNP ratio was useful for predicting the
recurrence of AF after direct current cardioversion in pa-
tients with mild chronic heart failure [11], which suggests
that the ANP-to-BNP ratio may be useful for predicting
the outcome of a maze procedure.
In the present study, we hypothesized that the preopera-
tive ANP-to-BNP ratio more accurately predicts the out-
come of a maze procedure in patients with mitral valve
disease than the known risk predictors. Furthermore, we
evaluated the ANP-to-BNP ratio as a biomarker for atrial
interstitial fibrosis, which is a pathological process that
has been associated with AF.
Methods
Patients
A total of 23 consecutive patients who had mitral valve
disease (13 mitral regurgitation, 6 mitral stenosis and re-
gurgitation, 4 mitral stenosis) and AF and underwent the
radial approach to the maze procedure [12] at Yamaguchi
University Hospital between April 2008 and December
2011 were examined. On the preoperative cardiac electro-
cardiogram, paroxysmal and chronic AF were documented
in 1 and 22 patients, respectively. Left atrial enlargement
was not used as an exclusion criterion. In addition, any
patients with ischemic heart disease or chronic kidney dis-
ease were not included in this study. The cardiac rhythm
after the maze procedure was assessed by electrocardiog-
raphy (n=21) or 24 hour electrocardiographic monitoring
(Holter) (n=2) 6 months after surgery and represented the
maze procedure outcome. Actually, SR was restored in 16
of 23 patients (69.6%). To elucidate a predictive factor for
maze procedure outcome, we divided the patients into SR
(n=16) and AF groups (n=7) based on postoperative car-
diac rhythm. Postoperatively, 2 patients with AF with slow
ventricular response in the AF group and 1 patient with
sick sinus symdrome in the SR group received permanent
pacemakers. All protocols in the present study were
approved by the Institutional Review Board of Yamaguchi
University Hospital, and all patients gave written informed
consent.
Measurement of plasma ANP and BNP levels
Blood samples were taken at rest before the operation.
Plasma ANP concentration was measured with a chemilu-
minescent enzyme immunoassay for α-human ANP (MI02Shionogi ANP; Shionogi Co., Lts., Osaka, Japan) as previ-
ously described [13]. Plasma BNP concentration was
measured with a chemiluminescent enzyme immunoassay
for BNP (E Test TOSOH II (BNP); TOSOH Corporation,
Tokyo, Japan) as previously described [14].
Quantitative assessment of atrial fibrosis
We examined interstitial fibrosis samples from the left
atrium, left atrial appendage, right atrium and right atrial
appendage of 16 patients in this study. The quantitative
collagen assay (No. 9046, Chondrex, Inc., Redmond, WA,
USA) was performed as previously described [15]. In brief,
atrial tissue samples were fixed in formalin and embedded
in paraffin. Ten-micrometer tissue sections were stained
with 0.1% Sirius red and 0.1% Fast green dissolved in wa-
ter saturated with picric acid for 30 minutes. The epicar-
dium, endocardium and microvessels in the sections were
then carefully removed under a microscope. The colour
eluted from the sections with a mixture of 0.1 N NaOH
and methanol (1:1) was read in a spectrophotometer at
540 nm and 605 nm. The net amounts of total collagen
and non-collagenous proteins were calculated using absor-
bances at 540 nm and 605 nm, respectively. The amount
of total proteins was the sum of both absorbance values.
Fibrosis was defined as follows: fibrosis (%) = (amount of
collagen protein / amount of total proteins) × 100.
Statistical analysis
Continuous data with was expressed as mean ± standard
deviation. Categorical variables were reported as frequen-
cies. Pre- and postoperative data were analysed using the
unpaired t-test and Fisher’s exact test. The unpaired t-test
was used for continuous variables with normal distribu-
tion. Fisher’s exact test was used for categorical variables.
Receiver operating characteristic (ROC) curve analysis
was used to identify factors that predict the outcomes of a
maze procedure. Associations between continuous vari-
ables were assessed using correlation and linear regression
techniques. P<0.05 was considered significant.
Results
Preoperative ANP-to-BNP ratio as a predictive factor for
maze procedure outcome
To elucidate a predictive factor for maze procedure out-
come, we compared preoperative variables between the
SR (n=16) and AF groups (n=7). There were no significant
differences in age, gender, CTR, left ventricular end-
diastolic dimension (LVDd), ejection fraction (EF) and the
preoperative ANP and BNP levels between two groups. In
contrast, there was significant difference in LAD and the
preoperative ANP-to-BNP ratio between the two groups
(p=0.031, p=0.025, respectively). The preoperative ANP-
to-BNP ratio was not identified as an independent factor
by the multivariate analysis (p=0.059), but compared to
Figure 1 ROC curve analysis in relation to the outcome after a
maze operation. ANP: atrial natriuretic peptide; BNP: brain natriuretic
peptide; CTR: cardiothoracic ratio; LAD: left atrial dimension.






Age (years) 65.1+/−12.4 70.4+/−5.6 0.290a
Gender (male/female) 8/8 2/5 0.405b
CTR (%) 55.2+/−7.5 61.9+/−5.9 0.051a
LVDd (mm) 53.8+/−8.9 51.0+/−7.0 0.554a
LAD (mm) 51.5+/−10.6 63.5+/−13.5 0.031a
EF (%) 64.7+/−7.0 68.7+/−7.3 0.234a
Preoperative creatinine(mg/dl) 0.97+/−0.02 1.10+/−0.18 0.384a
Preoperative ANP (pg/ml) 120.1+/−67.3 74.8+/−45.4 0.141a
Preoperative BNP (pg/ml) 186.4+/−113.9 191.9+/−72.2 0.909a
Preoperative ANP/BNP ratio 0.74+/−0.29 0.42/-0.28 0.025a
a Unpaired t test. bFisher’s exact test.
AF: atrial fibrillation; ANP: atrial natriuretic peptide; BNP: brain natriuretic
peptide; CTR: cardiothoracic ratio; EF: ejection fraction; LAD: left atrial
dimension;
LVDd: left ventricular end-diastolic dimension.
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most significant difference (Table 1).
To demonstrate the usefulness of the preoperative
ANP-to-BNP ratio as a predictive factor for maze proce-
dure outcome, ROC analysis was performed on the preop-
erative ANP-to-BNP ratio as well as ANP level, BNP level,
CTR and LAD. The area under the curve (AUC) for CTR
and LAD was 0.79 and 0.75, respectively, indicating that
CTR and LAD are also useful predictors of the outcome
of a maze procedure, which is consistent with previous re-
ports. Here, we found that the AUC for the preoperative
ANP-to-BNP ratio was 0.81 or higher than AUC for ANP
or BNP levels (Figure 1 and Table 2). Furthermore, the
cutoff value for the preoperative ANP-to-BNP ratio to pre-
dict the restoration of sinus rhythm after a maze procedure
was 0.41 (sensitivity 87.5%, specificity 71.4%). These find-
ings indicate that the preoperative ANP-to-BNP ratio is
the most useful for predicting the outcome of a maze pro-
cedure in patients with mitral valve disease.
Correlation between the preoperative ANP-to-BNP ratio
and atrial fibrosis
Next, we investigated the correlation between the preoper-
ative ANP-to-BNP ratio and atrial fibrosis. Figure 2 shows
representative sections stained with 0.1% Sirius red and
0.1% Fast green in the left atrium (A, E), left atrial append-
age (B, F), right atrium (C, G) and right atrial appendage
tissues (D, H) from patients with mild left atrial fibrosis
(upper panel) and severe left atrial fibrosis (lower panel).
In patients with mild and severe atrial fibrosis in the atrium,
the degree of fibrosis was similar in the left atrial append-
age, right atrium and right atrial appendage, but fibrosis (%)
in the left atrium was 6.2% in one of SR and 11.3% in one
of AF, respectively. Furthermore, in patients with mild and
severe atrial fibrosis, the preoperative ANP-to-BNP ratioswere 0.79 and 0.15, respectively. Interestingly, we found a
negative correlation between the preoperative ANP-to-BNP
ratio and fibrosis (%) in the left atrium (n=16, r=−0.69;
p<0.003) (Figure 3A). In contrast, there was no correlation
between the preoperative ANP-to-BNP ratio and fibrosis
(%) in the left atrial appendage, right atrium or right atrial
appendage (Figure 3B, C and D). In addition, neither ANP
nor BNP levels showed a correlation with fibrosis (%) in
any atrial tissues (data not shown).
We also observed that left atrial fibrosis (%) in the AF
group was significantly higher compared to that in the SR
group (AF group, 8.7 ± 2.4%; SR group, 6.2 ± 1.2%;
p=0.014, Figure 4). In contrast, mean fibrosis (%) in the
left atrial appendage, right atrium and right atrial append-
age in the AF group was slightly higher compared to that
in the SR group (data not shown).
Discussion
This is the first demonstration of a relationship between
the preoperative ANP-to-BNP ratio and maze procedure
outcome in patients with mitral valve disease. Atrial remo-
delling is important in maintaining AF. Intra-atrial conduc-
tion block, which leads to small and numerous reentrant
circuits, is caused by increased atrial fibrosis [16,17]. The
maze procedure was developed as a surgical treatment for
AF. In the maze procedure, interruption lines are placed to
block the reentrant circuits. Therefore, an unsuccessful
maze procedure may be the result of smaller reentrant
circuits. The maze procedure cures AF in most patients
with lone AF [3]. In contrast, the success rates of the maze
procedure for patients with AF and mitral valve disease,
which induces the progression of left atrial remodelling,
have been reported to be between 60% and 90% and have
remained unsatisfactory [4,5]. Because the progression of
mitral valve disease is associated with structural changes
Table 2 Area under the curve for ANP-to-BNP ratio, ANP,
BNP, CTR and LAD
AUC p value 95% confidence interval
Preoperative ANP/BNP ratio 0.81 0.02 0.61 – 1.00
Preoperative ANP 0.73 0.08 0.50 – 0.96
Preoperative BNP 0.55 0.69 0.30 – 0.81
CTR 0.79 0.29 0.61 – 0.97
LAD 0.75 0.06 0.52 – 0.98
ANP: atrial natriuretic peptide; AUC: area under the curve; BNP: brain natriuretic
peptide; CTR: cardiothoracic ratio; LAD: left atrial dimension.
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efficacy of the maze procedure is theoretically limited in
the patients with severe mitral valve disease. In addition,
the maze procedure is an invasive treatment and has
several disadvantages, including prolonged operation time.
This has raised concerns that this procedure may result in
increased mortality in patient subsets less likely to benefit
from the procedure. To avoid an unnecessary or excessive
procedure, a useful predictive marker for maze procedure
outcome is necessary, especially for patients with mitral
valve disease. Hence, we sought to identify a preoperative
factor that predicts maze procedure outcome. Large LAD
and increased CTR were previously reported as risk
factors for recurring AF after a maze procedure [7,8].
Yoshihara et al. reported that plasma ANP level also pre-
dicts maze procedure outcome [6]. In this study, CTR and
plasma ANP levels were not predictors of maze procedure
outcome. This may be due to the small sample size in our
current study. Despite the small sample size, we have suc-
ceeded in identifying the preoperative ANP-to-BNP ratio
as the most powerful predictor of maze procedure out-
come. In addition, we showed that the preoperative ANP-
to-BNP ratio was the best discriminator between patients
with and without postoperative persistent AF (discrimina-
tor value=0.41). Using this cutoff value, the sensitivity and
the specificity are 87.5% and 71.4% for predicting theFigure 2 Representative sections stained with 0.1% Sirius red and 0.1
right atrium (C, G) and right atrial appendage (D, H) of patients with
(lower panel). Scale bar=200 μm.restoration of sinus rhythm after a maze procedure. These
results should lead to an increased success rate for the
maze procedure. This strongly suggests that the preopera-
tive ANP-to-BNP ratio is a promising tool for identifying
the appropriate patients for the maze procedure.
We have also found that the preoperative ANP-to-BNP
ratio is correlated with left atrial fibrosis. Although in-
creased left atrial fibrosis is thought to be associated with
the progression of mitral valve disease and failure of the
maze procedure, the role of left atrial fibrosis in the devel-
opment, recurrence and persistence of AF has not been
fully elucidated. Saito and colleagues reported a correla-
tion between the postoperative recurrence of AF and
fibrosis in the left atrial appendage [18]. Kataoka et al.
also reported that fibrosis in the left atrial appendage
was significantly increased in patients in whom AF per-
sisted after surgery [9]. Unfortunately, they did not
assess left atrial interstitial fibrosis in their studies. In
this study, we examined interstitial fibrosis in the left
atrium, left atrial appendage, right atrium and right atrial
appendage and found a considerable difference only in left
atrial fibrosis between the SR and AF groups. Therefore,
measuring left atrial fibrosis may be useful in determining
the prognosis of patients with AF and mitral valve disease
who underwent mitral valve surgery with a concomitant
maze procedure. Moreover, the preoperative ANP-to-BNP
ratio may also be a potential clinical biomarker for left
atrial interstitial fibrosis.
Currently, the precise mechanism by which the preoper-
ative ANP-to-BNP ratio is negatively correlated with left
atrial fibrosis remains unknown. ANP is produced, stored
and released by atrial cardiomyocytes in response to atrial
stretch. It has been also reported that the decrease in
plasma ANP is caused by the progression of atrial fibrosis
[19]. This suggests that ANP by itself may be a potential
biomarker for atrial fibrosis. Indeed, it has been reported
that plasma ANP concentration inversely correlates with% Fast green in the left atrium (A, E), left atrial appendage (B, F),
mild left atrial fibrosis (upper panel) and severe left atrial fibrosis
Figure 4 Comparison between SR and AF groups for atrial
fibrosis (%). SR: sinus rhythm; AF: atrial fibrillation.
Figure 3 Correlations between plasma ANP-to-BNP ratio and fibrosis (%) in the left atrium (A), left atrial appendage (B), right atrium
(C) and right atrial appendage (D). ANP: atrial natriuretic peptide; BNP: brain natriuretic peptide.
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come of a maze procedure [6]. However, in patients with
mitral regurgitation or stenosis, there is a concern that
ANP may be influenced not only by atrial fibrosis but also
by an increased pressure or volume load in the atria [20].
By contrast, BNP is mainly produced and secreted by the
ventricles in response to ventricular overload [20]. In pa-
tients with mitral regurgitation, plasma BNP increases with
the severity of mitral regurgitation [21]. Mitral regurgita-
tion causes volume overload with left atrial enlargement
and left ventricular remodelling and induces BNP activa-
tion [10]. In patients with mitral stenosis, the degree of
mitral stenosis has been shown to correlate with plasma
BNP level, which is mainly produced by right ventricular
myocytes due to right ventricular overload [22]. There is
also positive correlation between plasma BNP level and
LAD in patients with mitral stenosis [23]. As a result,
ANP secretion in a patient with mitral valve disease is re-
duced according to the progression of the LA remodelling
and enhanced overload, and the secretion of BNP is in-
creased due to LA remodelling in patients with mitral re-
gurgitation and stenosis. Therefore, the ratio of ANP to
BNP may represent the degree of atrial fibrosis, that is
necessary to counter the effect of pressure and volume
load on the secretion of ANP. The ratio of ANP to BNP
may be a better biomarker for atrial fibrosis than ANP by
itself. In this study, we clearly demonstrated that the
preoperative ANP-to-BNP ratio is much more useful inpredicting the outcome of a maze procedure and assessing
left atrial fibrosis than either plasma ANP or BNP alone.
This study has some limitations. Although we ob-
served a significant correlation between the preoperative
ANP-to-BNP ratio and maze procedure outcome, the
sample size was quite small. Further studies with larger
sample sizes are needed to establish the usefulness of
the preoperative ANP-to-BNP ratio. We assessed the
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and by 24-hour electrocardio-monitoring in the remain-
ing 2 patients. Therefore, the success rate after the maze
procedure may be overestimated. In a previous study,
when the use of electrocardiography was compared with
24-hour electrocardio-monitoring, the detection rate of
AF recurrence differed by 5.5%. However, the difference
was not statistically significant [24]. In addition, even
though we did not exclude such patients intentionally,
no patients with ischemic heart disease or chronic kid-
ney disease were enrolled in this study. BNP secretion
was influenced not only by myocardial stretch but also
by the ischemic insult [25]. It has also been reported that
BNP is higher in patients with chronic kidney disease
than in those without the disease [26]. These findings
raise the possibility that the effectiveness of the preoper-
ative ANP-to-BNP ratio may be decreased in patients
with ischemic heart disease and/or chronic kidney disease.
Therefore, the usefulness of preoperative ANP-to-BNP
ratio in such patients should be examined in future
studies.
Conclusion
In conclusion, our findings demonstrate that the preop-
erative ANP-to-BNP ratio correlates negatively with left
atrial fibrosis, predicts the outcome of a maze proce-
dure in patients with mitral valve disease and represents
a new biomarker that helps to decide when to perform a
maze procedure.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MS developed study protocol, obtained data, analyzed data and wrote
manuscript. AM developed the study protocol and provided critical revision
of the manuscript. HK, RS, MM, TK, KY, and KH provided critical revision of
the manuscript. All authors read and approved the final manuscript.
Author details
1Department of Surgery and Clinical Science, Division of Cardiac Surgery,
Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi,
Ube, Yamaguchi 755-8505, Japan. 2Faculty of Nursing and Nutrition,
Yamaguchi Prefectural University, 3-2-1 Sakurabatake, Yamaguchi, Yamaguchi
753-0021, Japan.
Received: 1 December 2012 Accepted: 27 February 2013
Published: 28 February 2013
References
1. Bando K, Kasegawa H, Okada Y, Kobayashi J, Kada A, Shimokawa T, Nasu M,
Nakatani S, Niwaya K, Tagusari O, et al: Impact of preoperative and
postoperative atrial fibrillation on outcome after mitral valvuloplasty for
nonischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005,
129(5):1032–1040.
2. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-Sarano M:
Outcome of valve repair and the Cox maze procedure for mitral
regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg
1999, 118(4):628–635.
3. Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP, Sundt TM 3rd,
Cox JL, Damiano RJ Jr: The Cox maze III procedure for atrial fibrillation:long-term efficacy in patients undergoing lone versus concomitant
procedures. J Thorac Cardiovasc Surg 2003, 126(6):1822–1828.
4. Wellens F, Casselman F, Geelen P, Brugada P, Van Praet F, De Geest R,
Degrieck I, Vanermen H: Combined atrial fibrillation and mitral valve
surgery using radiofrequency technology. Semin Thorac Cardiovasc Surg
2002, 14(3):219–225.
5. Gillinov AM, Saltman AE: Ablation of atrial fibrillation with concomitant
cardiac surgery. Semin Thorac Cardiovasc Surg 2007, 19(1):25–32.
6. Yoshihara F, Nishikimi T, Sasako Y, Hino J, Kobayashi J, Minatoya K, Bando K,
Kosakai Y, Horio T, Suga S, et al: Plasma atrial natriuretic peptide
concentration inversely correlates with left atrial collagen volume
fraction in patients with atrial fibrillation: plasma ANP as a possible
biochemical marker to predict the outcome of the maze procedure.
J Am Coll Cardiol 2002, 39(2):288–294.
7. Bando K, Kobayashi J, Kosakai Y, Hirata M, Sasako Y, Nakatani S, Yagihara T,
Kitamura S: Impact of Cox maze procedure on outcome in patients with
atrial fibrillation and mitral valve disease. J Thorac Cardiovasc Surg 2002,
124(3):575–583.
8. Isobe F, Kawashima Y: The outcome and indications of the Cox maze III
procedure for chronic atrial fibrillation with mitral valve disease.
J Thorac Cardiovasc Surg 1998, 116(2):220–227.
9. Kataoka T, Hamasaki S, Inoue K, Yuasa T, Tomita K, Ishida S, Ogawa M,
Saihara K, Koriyama C, Nobuyoshi M, et al: Left atrium volume index and
pathological features of left atrial appendage as a predictor of failure in
postoperative sinus conversion. J Cardiol 2010, 55(2):274–282.
10. Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr,
Enriquez-Sarano M: B-type natriuretic peptide in organic mitral
regurgitation: determinants and impact on outcome. Circulation 2005,
111(18):2391–2397.
11. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M: Plasma cardiac natriuretic
peptides as biochemical markers of recurrence of atrial fibrillation in
patients with mild congestive heart failure. Jpn Circ J 2000,
64(10):765–771.
12. Nitta T, Lee R, Schuessler RB, Boineau JP, Cox JL: Radial approach: a new
concept in surgical treatment for atrial fibrillation I. Concept, anatomic
and physiologic bases and development of a procedure. Ann Thorac Surg
1999, 67(1):27–35.
13. Ken-ichi S, Tsutayo H, Akiko T, Toshio S, Hitoshi T, Toshihiko F: Evaluation of
automated chemiluminescent enzyme imunoassay analyzer exclusive kit
“MIO2 Shionogi ANP”. Jpn J Med Pharm Sci 2007, 57(6):901–906.
14. Yoshitomo N, Emi F, Hiroshi S, Junichi M, Yutaka I: Evaluation of plasma
brain natriuretic peptide concentration used by AIA-360. Jpn J Med
Pharm Sci 2004, 52(3):397–402.
15. Lopez-De Leon A, Rojkind M: A simple micromethod for collagen and
total protein determination in formalin-fixed paraffin-embedded
sections. J Histochem Cytochem 1985, 33(8):737–743.
16. Li D, Fareh S, Leung TK, Nattel S: Promotion of atrial fibrillation by heart
failure in dogs: atrial remodeling of a different sort. Circulation 1999,
100(1):87–95.
17. Allessie M, Ausma J, Schotten U: Electrical, contractile and structural
remodeling during atrial fibrillation. Cardiovasc Res 2002, 54(2):230–246.
18. Saito T, Tamura K, Uchida D, Togashi M, Nitta T, Sugisaki Y:
Histopathological features of the resected left atrial appendage as
predictors of recurrence after surgery for atrial fibrillation in valvular
heart disease. Circ J 2007, 71(1):70–78.
19. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Nishimura T, Yamada H, Sasaki
Y, Kinoshita M: Low dose synthetic human atrial natriuretic peptide
infusion in a patient with mitral stenosis and severe pulmonary
hypertension. Jpn Circ J 1999, 63(10):816–818.
20. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M,
Nakao K, Imura H: Different secretion patterns of atrial natriuretic peptide
and brain natriuretic peptide in patients with congestive heart failure.
Circulation 1993, 87(2):464–469.
21. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, Kerr AJ:
Plasma natriuretic peptide levels increase with symptoms and severity
of mitral regurgitation. J Am Coll Cardiol 2003, 41(12):2280–2287.
22. Eryol NK, Dogan A, Ozdogru I, Inanc MT, Kaya MG, Kalay N: The relationship
between the level of plasma B-type natriuretic peptide and mitral
stenosis. Int J Cardiovasc Imaging 2007, 23(5):569–574.
23. Arat-Ozkan A, Kaya A, Yigit Z, Balci H, Okcun B, Yazicioglu N, Kucukoglu S:
Serum N-terminal pro-BNP levels correlate with symptoms and
Sato et al. Journal of Cardiothoracic Surgery 2013, 8:32 Page 7 of 7
http://www.cardiothoracicsurgery.org/content/8/1/32echocardiographic findings in patients with mitral stenosis.
Echocardiography 2005, 22(6):473–478.
24. Ad N, Henry L, Hunt S, Barnett S, Stone L: The Cox-Maze III procedure
success rate: comparison by electrocardiogram, 24-hour holter
monitoring and long-term monitoring. Ann Thorac Surg 2009,
88(1):101–105.
25. Morrow DA, Braunwald E: Future of biomarkers in acute coronary
syndromes: moving toward a multimarker strategy. Circulation 2003,
108(3):250–252.
26. Marumoto K, Hamada M, Hiwada K: Increased secretion of atrial and brain
natriuretic peptides during acute myocardial ischaemia induced by
dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 1995,
88(5):551–556.
doi:10.1186/1749-8090-8-32
Cite this article as: Sato et al.: Ratio of preoperative atrial natriuretic
peptide to brain natriuretic peptide predicts the outcome of the maze
procedure in mitral valve disease. Journal of Cardiothoracic Surgery 2013
8:32.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
